Compare ATS & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATS | GRDN |
|---|---|---|
| Founded | 1978 | 2004 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Retail-Drug Stores and Proprietary Stores |
| Sector | | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.4B |
| IPO Year | 2007 | 2023 |
| Metric | ATS | GRDN |
|---|---|---|
| Price | $19.45 | $42.45 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $35.00 | ★ $40.60 |
| AVG Volume (30 Days) | 216.1K | ★ 359.5K |
| Earning Date | 05-27-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $1,448,685,000.00 |
| Revenue This Year | $17.99 | N/A |
| Revenue Next Year | $4.52 | $7.63 |
| P/E Ratio | $222.92 | ★ $117.77 |
| Revenue Growth | N/A | ★ 17.93 |
| 52 Week Low | $18.41 | $23.18 |
| 52 Week High | $35.82 | $47.02 |
| Indicator | ATS | GRDN |
|---|---|---|
| Relative Strength Index (RSI) | 37.27 | 68.04 |
| Support Level | $19.14 | $38.49 |
| Resistance Level | $20.11 | $43.56 |
| Average True Range (ATR) | 0.50 | 1.33 |
| MACD | 0.29 | 0.65 |
| Stochastic Oscillator | 53.24 | 100.00 |
ATS Corp is engaged in planning, designing, building, commissioning and servicing automated manufacturing systems - including automation products and test solutions - for a broadly diversified base of customers. The company focuses in five key markets: life sciences, food & beverage, transportation, consumer products and energy. The Company's operations are reported as one operating segment, Automation Systems, which plans, allocates resources, builds capabilities and implements practices on a world-wide basis. The company has presence in Canada, United States, Germany, Italy, Other Europe, and Other.
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.